IGM Biosciences, Inc. (IGMS) Financials
IGMS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 423.4 million | 220.2 million |
2023-09-30 | 474.4 million | 220.5 million |
2023-06-30 | 480.7 million | 222.1 million |
2023-03-31 | 462.7 million | 223.3 million |
IGMS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -49.5 million | 9.2 million |
2023-09-30 | -43.2 million | 12.0 million |
2023-06-30 | -57.0 million | 14.3 million |
2023-03-31 | -54.9 million | 11.0 million |
IGMS Net Income
No data available :(
IGMS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 338.3 million | - | 40.5 million |
2023-09-30 | 387.0 million | - | 41.2 million |
2023-06-30 | 386.9 million | - | 41.4 million |
2023-03-31 | 373.4 million | - | 41.3 million |
IGMS Shares Outstanding
IGMS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.4 million | 52.0 million | 11.6 million | - |
2023-09-30 | 3.1 million | 54.8 million | 12.5 million | - |
2023-06-30 | 3.9 million | 55.7 million | 13.0 million | - |
2023-03-31 | 3.9 million | 50.9 million | 13.0 million | - |
IGMS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 651000 | 2.2 million |
2023-09-30 | 509000 | 2.3 million |
2023-06-30 | 448000 | 3.5 million |
2023-03-31 | 522000 | 3.0 million |
IGMS
Price: $9.43
52 week price:
Earnings Per Share: -4.71 USD
P/E Ratio: -2.96
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 224815
Market Capitalization: 515.0 million